At 12 months , Child-Turcotte Pugh scores were reduced by 48.6 % in the GDP group and 39.1 % in the control group , from baseline ( P = .001 ) ; Model for End Stage Liver Disease scores were reduced by 40.4 % and 33 % , respectively ( P = .03 ) .